What Researchers Did
Researchers conducted a case-control study with 413 patients to see if adding hyperbaric oxygen therapy (HBOT) to steroid treatment improved hearing recovery for idiopathic sudden sensorineural hearing loss (ISSNHL).
What They Found
Initially, before balancing patient characteristics, there was a significant difference in hearing recovery rates (p = 0.02). However, after carefully matching 135 patients in each group based on similar characteristics, the study found no statistically significant difference in overall hearing recovery between those who received steroids alone and those who received steroids combined with HBOT (p = 0.180). This suggests that HBOT, when added to intravenous and intratympanic steroid therapy, did not provide additional improvement in outcomes.
What This Means for Canadian Patients
For Canadian patients experiencing idiopathic sudden sensorineural hearing loss, this study suggests that adding hyperbaric oxygen therapy to initial steroid treatment may not provide extra benefits for hearing recovery. Patients should discuss all treatment options with their healthcare providers to make informed decisions about their care.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a single-center case-control study, which may limit how broadly its findings can be applied.